Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorKafrelsheikh University
About this trial
The aim of this work is to evaluate the effect of combined intrathecal dexmedetomidine and adductor canal block for analgesia after total knee arthroplasty (TKA).
Eligibility criteria
Qualifiers
Age from 18 to 75 years.
Both sexes.
American Society of Anesthesiology (ASA) physical status I-II.
Scheduled for total knee arthroplasty under spinal anesthesia.
Disqualifiers
Patients with neurological or intellectual disability.
History of allergy to local anesthetics or dexmedetomidine .
Infection at the injection site.
Prolonged use of analgesic or sedative medications.
Trial design
Treatments tested in this trial
- Intrathecal Dexmedetomidine
- Adductor Canal Block
- Intrathecal Dexmedetomidine + Adductor Canal Block
Treatment groups
75 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov